Vitality Biopharma Hires Investment decision Financial institution To Discover M&A, Asset Sale Alternatives

Drug advancement business Vitality Biopharma Inc. (OTCQB:VBIO) has tapped financial adviser DelMorgan & Co. to regulate a likely sale approach. Neil Morganbesser, DelMorgan’s President and CEO, said “the correct lover — either by means of M&A or a cash infusion — could be the important to unlocking Vitality’s explosive expansion potential.” Vitality’s portfolio is made up of cannabinoid medicine and […]